Dr Wen Yen Chen, MD in Dededo, GU - Pediatrics

Dr Wen Yen Chen, MD is a Pediatrics physician based in Dededo, Guam. Dr Wen Yen Chen is licensed to practice in Guam (license number 417) and his current practice location is 330 W Marine Corps Dr, Dededo, Guam. He can be reached at his office (for appointments etc.) via phone at (671) 637-8112.

NPI number for Dr Wen Yen Chen is 1366692956 and his current mailing address is 330 W Marine Corps Dr, Dededo, Guam. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1366692956.

Contact Information

	Dr Wen Yen Chen, MD
	330 W Marine Corps Dr, Dededo, GU 96929-5929
	(671) 637-8112
	(671) 637-8113

Physician's Profile

Full Name	Dr Wen Yen Chen
Gender	Male
Speciality	Pediatrics
Location	330 W Marine Corps Dr, Dededo, Guam
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1366692956
Provider Enumeration Date: 09/19/2008
Last Update Date: 09/19/2008

Medical Identifiers

Medical identifiers for Dr Wen Yen Chen such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1366692956	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	417 (Guam)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Wen Yen Chen is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Wen Yen Chen, MD 330 W Marine Corps Dr, Dededo, GU 96929-5929 Ph: (671) 637-8112	Dr Wen Yen Chen, MD 330 W Marine Corps Dr, Dededo, GU 96929-5929 Ph: (671) 637-8112

News Archive

Scientific community must fight misconceptions about experiments using animals: Researchers

In a recent commentary, We must face the threats, in the Journal of Neuroscience, researchers Dario Ringach and David Jentsch spoke out against animal rights extremism. They urged the scientific community to stand together and fight misconceptions about experiments using animals. That their plea has been heard is clear from the unanimously positive response it received on the Faculty of 1000 Biology website.

Dermatitis management

Although the variety of substances that can cause contact dermatitis is almost limitless, it often can be effectively managed with the proper diagnosis and treatment according to investigators presenting the latest research at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Seattle.

Sickle cell disease trial completes phase 3 patient enrollment

Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine company, today announced the completion of patient enrollment for its phase 3 clinical trial to study L-glutamine as a treatment for sickle cell disease.

Neonatal vaccination of mice with bacteria prevents cockroach-induced asthma as adults

The hygiene hypothesis proposes that a 20th century surge in allergies and asthma is because people are living in increasingly hygienic environments.

MedImmune to present Phase IIb asthma data on benralizumab and tralokinumab at ATS conference

AstraZeneca today announced that MedImmune, its global biologics research and development arm, will present Phase IIb data on two novel investigational molecules – benralizumab and tralokinumab – at the upcoming American Thoracic Society 2014 International Conference being held in San Diego, California, 16-21 May.

Dr Wen Yen Chen, MD - Pediatrics in Dededo, GU